packagePozelimab

pozelimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pozelimab is a monoclonal antibody that acts as a complement inhibitor, developed as an immunosuppressant medication. It has been approved and is also being studied in clinical trials; it is not an established widely used therapy.

Summary written by glm-5.3-flash from Wikidata Q121708361 and the WHO ATC classification; not checked by a person.

name:pozelimab
ATC codes:L04AJ11
DrugBank:DB15218
Wikidata:Q121708361

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown